Taysha Gene Therapies, Inc. (TSHA)
6.39
+0.12
(+1.91%)
USD |
NASDAQ |
Apr 30, 16:00
6.375
-0.02
(-0.23%)
After-Hours: 20:00
Taysha Gene Therapies EPS Diluted (Quarterly) : -0.0977 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.2025 |
| Praxis Precision Medicines, Inc. | -3.500 |
| Aveanna Healthcare Holdings, Inc. | 0.7997 |
| Palisade Bio, Inc. | -0.0558 |
| Structure Therapeutics, Inc. | 0.56 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.85M |
| Revenue (Quarterly) | 5.485M |
| Total Expenses (Quarterly) | 33.34M |
| Enterprise Value | 1.586B |
| Gross Profit Margin (Quarterly) | 94.55% |
| Profit Margin (Quarterly) | -507.8% |
| Earnings Yield | -5.64% |
| Normalized Earnings Yield | -5.372 |